Jade Biosciences (JBIO) Interest & Investment Income (2020 - 2026)
Jade Biosciences posted quarterly Interest & Investment Income of $3.1 million for Q1 2026, up 404.39% year-on-year from $615000.0 in Q1 2025, and up 0.55% on a QoQ basis from $3.1 million in Q4 2025.
Jade Biosciences (JBIO) has 7 years of Interest & Investment Income data on file, last reported at $3.1 million in Q1 2026.
- For the quarter ending Q1 2026, Interest & Investment Income rose 404.39% year-over-year to $3.1 million; the trailing twelve-month figure through Mar 2026 stood at $10.3 million (up 374.98% YoY), and the FY2025 full-year result was $7.8 million, up 54.34% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $3.1 million, up from $3.1 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $3.1 million in Q1 2026 and bottomed at $109000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $1.2 million (2023), against an average of $1.4 million.
- The widest annual swing landed in 2022, when Interest & Investment Income soared 11400.0%; it then sank 78.49% in 2024.
- A 5-year view of Interest & Investment Income shows it stood at $932000.0 in 2022, then surged by 83.37% to $1.7 million in 2023, then tumbled by 32.18% to $1.2 million in 2024, then jumped by 166.18% to $3.1 million in 2025, then rose by 0.55% to $3.1 million in 2026.
- The last three Interest & Investment Income figures came in at $3.1 million (Q1 2026), $3.1 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Jade Biosciences | 1.06 Bn | 1.06 Bn | - | 3.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.10 Mn |
| Dec 31, 2025 | 3.09 Mn |
| Sep 30, 2025 | 2.25 Mn |
| Jun 30, 2025 | 1.83 Mn |
| Mar 31, 2025 | 615,000.00 |
| Dec 31, 2024 | 1.16 Mn |
| Sep 30, 2024 | 388,000.00 |
| Mar 31, 2024 | 1.44 Mn |
| Dec 31, 2023 | 1.71 Mn |
| Sep 30, 2023 | 1.80 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | 932,000.00 |
| Sep 30, 2022 | 560,000.00 |
| Jun 30, 2022 | 230,000.00 |
| Mar 31, 2022 | 109,000.00 |
| Dec 31, 2021 | 47,000.00 |
| Sep 30, 2021 | 16,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Jun 30, 2020 | -37,000.00 |